N-(1-Methylcyclopropyl)-3-[(1-methylpyrazol-4-yl)methyl]-1-(oxetan-3-ylmethyl)-2,4-dioxo-quinazoline-6-sulfonamide

SI-2113

N-(1-Methylcyclopropyl)-3-[(1-methylpyrazol-4-yl)methyl]-1-(oxetan-3-ylmethyl)-2,4-dioxo-quinazoline-6-sulfonamide, >98% (HPLC)

CAS No. : [1945951-55-2]

IUPAC Name : 3-((1-Methyl-1H-pyrazol-4-yl)methyl)-N-(1-methylcyclopropyl)-1-(oxetan-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
25MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
100MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
Note: SI-2113 is not in stock but can be available through custom synthesis. The estimated lead-time is 8-10 weeks. The product will be characterized by NMR and Mass analysis. Purity (HPLC) is usually >98%. COA, QC data and SDS will be provided along with the product. For information on pricing and availability please contact us at sales@syninnova.com or Request A Quote. We respond promptly. Thank You!

Applications : SI-2113 is novel quinazolinedione sulfonamide poly(ADP-ribose) glycohydrolase {PARG) inhibitor.

References : Waszkowycz B. et al.: J. Med. Chem., 61(23), 10767-10792, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.